image credit: Adobe Stock

Thermo Fisher, Charles River join robotics outfit Multiply Labs’ quest to automate cell therapy production

May 5, 2022

On a quest to automate manual portions of the cell therapy production process, Multiply Labs is arming itself with two more pieces of industry-leading tech. The new kit comes on board a little less than a year after the robotics outfit unveiled a consortium aimed at building a robotic manufacturing system to make cell therapies on an industrial scale.

After recruiting an initial team that included Cytiva and the University of California, San Francisco (UCSF), Multiply Labs is adding major players in Thermo Fisher Scientific and Charles River Laboratories, the companies said Thursday.

Read More on FiercePharma